论文部分内容阅读
异烟肼、氨硫脲等结核病新药试用以来,初步证明已获有一定的成效。京沪等地均曾做了一些临床实验,但由于诊断分类的方法不统一,研究的方法和考核的标准也都不一致,加以病例太少,有些报告也写得简单、抽象,所以尚难得出一个肯定的结论。中央人民政府卫生部为了明确这些药品的疗效价值与使用剂量,研究如何解决抗药性等有关问题,特委托中国防痨协会进行一千个病例的实验与研究。
Isoniazid, ammonia thiourea and other new TB drugs since the trial, the initial evidence has been a certain effect. Beijing-Shanghai and other places have done some clinical experiments, but because of the diagnostic methods are not uniform classification, research methods and assessment of the standards are inconsistent, to be too few cases, some reports are also written simple and abstract, it is difficult to draw A positive conclusion. The Central People’s Government Ministry of Health in order to clarify the efficacy of these drugs and the use of dose, study how to solve the drug resistance and other related issues, commissioned by China Antituberculosis Association for a thousand cases of experimental and research.